SARS-CoV-2 reinfections in a US university setting, Fall 2020 to Spring 2021
dc.contributor.author | Rosenberg, Molly | |
dc.contributor.author | Chen, Chen | |
dc.contributor.author | Golzarri‑Arroyo, Lilian | |
dc.contributor.author | Carroll, Aaron | |
dc.contributor.author | Menachemi, Nir | |
dc.contributor.author | Ludema, Christina | |
dc.contributor.department | Health Policy and Management, School of Public Health | en_US |
dc.date.accessioned | 2023-07-17T14:49:32Z | |
dc.date.available | 2023-07-17T14:49:32Z | |
dc.date.issued | 2022-07-04 | |
dc.description.abstract | Background: SARS-CoV-2 reinfections are a public health concern because of the potential for transmission and clinical disease, and because of our limited understanding of whether and how well an infection confers protection against subsequent infections. Despite the public health importance, few studies have reported rigorous estimates of reinfection risk. Methods: Leveraging Indiana University's comprehensive testing program to identify both asymptomatic and symptomatic SARS-CoV-2 cases, we estimated the incidence of SARS-CoV-2 reinfection among students, faculty, and staff across the 2020-2021 academic year. We contextualized the reinfection data with information on key covariates: age, sex, Greek organization membership, student vs faculty/staff affiliation, and testing type. Results: Among 12,272 people with primary infections, we found a low level of SARS-CoV-2 reinfections (0.6%; 0.4 per 10,000 person-days). We observed higher risk for SARS-CoV-2 reinfections in Greek-affiliated students. Conclusions: We found evidence for low levels of SARS-CoV-2 reinfection in a large multi-campus university population during a time-period prior to widespread COVID-19 vaccination. | en_US |
dc.eprint.version | Final published version | en_US |
dc.identifier.citation | Rosenberg M, Chen C, Golzarri-Arroyo L, Carroll A, Menachemi N, Ludema C. SARS-CoV-2 reinfections in a US university setting, Fall 2020 to Spring 2021. BMC Infect Dis. 2022;22(1):592. Published 2022 Jul 4. doi:10.1186/s12879-022-07578-x | en_US |
dc.identifier.uri | https://hdl.handle.net/1805/34415 | |
dc.language.iso | en_US | en_US |
dc.publisher | BMC | en_US |
dc.relation.isversionof | 10.1186/s12879-022-07578-x | en_US |
dc.relation.journal | BMC Infectious Diseases | en_US |
dc.rights | Attribution 4.0 International | * |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
dc.source | PMC | en_US |
dc.subject | SARS-CoV-2 | en_US |
dc.subject | COVID-19 | en_US |
dc.subject | Reinfection | en_US |
dc.subject | Asymptomatic infection | en_US |
dc.subject | University settings | en_US |
dc.title | SARS-CoV-2 reinfections in a US university setting, Fall 2020 to Spring 2021 | en_US |
dc.type | Article | en_US |